#81, Thinking Big to Improve Liver Disease Outcomes, Quin Wills from Ochre Bio
2024-03-20
0:00
27:30
Quin Wills, Co-Founder & CSO of Ochre Bio, joins us to discuss their use of deep analysis of liver genetics and precision RNA design to develop new therapies for liver diseases like hepatitis, cirrhosis and liver cancer.
Fler avsnitt från "AWS Health Innovation Podcast"
Missa inte ett avsnitt av “AWS Health Innovation Podcast” och prenumerera på det i GetPodcast-appen.